Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study

NCT05015764 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-04-04

No results posted yet for this study

Summary

Reprieve Cardiovascular System for the Treatment of Subjects with Acute Decompensated Heart Failure Mechanistic Study

Conditions

Interventions

OTHER

Fluid Management

Removal of excess extracellular fluid using diuretics

DEVICE

Reprieve Cardiovascular System

System with Fluid Management Module

Sponsors & Collaborators

  • Reprieve Cardiovascular, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2022-05-02
Completion
2022-05-02
FDA Device
Yes

Countries

  • Georgia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05015764 on ClinicalTrials.gov